STRO earnings
Sutro Biopharma (STRO) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- STRO beat EPS estimates in 3 of its last 15 reports.
STRO earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | -1.90 | -1.64 | -15.85% | $9.10M |
| Q2 2026 | Aug 12, 2026 | -2.33 | -2.19 | -6.39% | $9.84M |
| Q1 2026 | May 14, 2026 | -2.94 | -2.32 | -26.72% | $14.52M |
| Q3 2025 | Nov 6, 2025 | -6.70 | -3.94 | -69.85% | $9.69M |
| Q2 2025 | Aug 7, 2025 | -1.40 | – | – | $63.74M |
| Q1 2025 | May 8, 2025 | -9.10 | -6.30 | -44.44% | $17.40M |
| Q4 2024 | Mar 13, 2025 | -8.90 | -8.30 | -7.18% | $14.81M |
| Q3 2024 | Nov 13, 2024 | -5.90 | -0.95 | -517.80% | $8.52M |
| Q2 2024 | Aug 13, 2024 | -5.90 | -7.60 | 22.37% | $25.71M |
| Q1 2024 | May 13, 2024 | -9.50 | -9.20 | -3.26% | $13.01M |
| Q4 2023 | Mar 25, 2024 | 4.20 | -0.82 | 612.20% | $113.72M |
| Q3 2023 | Nov 13, 2023 | -8.10 | -0.82 | -887.80% | $16.92M |
| Q2 2023 | Aug 10, 2023 | -6.40 | -0.73 | -773.72% | $10.41M |
| Q1 2023 | May 15, 2023 | -0.85 | -0.83 | -2.41% | $12.67M |
| Q4 2022 | Mar 30, 2023 | -6.10 | -0.64 | -853.12% | $8.63M |
| Q3 2022 | Nov 8, 2022 | -0.37 | -0.74 | 50.00% | $25.15M |